Louis Miramontes - Rite Aid Independent Director
| RTA1 Stock | EUR 0.20 0.00 0.00% |
Insider
Louis Miramontes is Independent Director of Rite Aid since 2018.
| Age | 64 |
| Tenure | 6 years |
| Phone | 717 761 2633 |
| Web | https://www.riteaid.com |
Louis Miramontes Latest Insider Activity
Tracking and analyzing the buying and selling activities of Louis Miramontes against Rite Aid stock is an integral part of due diligence when investing in Rite Aid. Louis Miramontes insider activity provides valuable insight into whether Rite Aid is net buyers or sellers over its current business cycle. Note, Rite Aid insiders must abide by specific rules, including filing SEC forms every time they buy or sell Rite Aid'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Louis Miramontes over three months ago Disposition of 300 shares by Louis Miramontes of Lithia Motors at 284.23 subject to Rule 16b-3 |
Rite Aid Management Efficiency
Rite Aid's management efficiency ratios could be used to measure how well Rite Aid manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Rosalind Brewer | Walgreens Boots Alliance | 61 | |
| Hidehiko Tsukada | Sugi Holdings CoLtd | N/A | |
| Mia Scholz | Walgreens Boots Alliance | 57 | |
| Fei Chen | Beijing Tong Ren | 52 | |
| Aaron Radelet | Walgreens Boots Alliance | N/A | |
| Ka Chun | Alibaba Health Information | N/A | |
| Shunyan Zhu | Alibaba Health Information | 52 | |
| Danielle Gray | Walgreens Boots Alliance | 44 | |
| Chun Kwong | Alibaba Health Information | N/A | |
| Chun Yan | Alibaba Health Information | N/A | |
| Yanwu Tu | Alibaba Health Information | 44 | |
| Naoto Mochizuki | Sugi Holdings CoLtd | N/A | |
| Katsunori Sugiura | Sugi Holdings CoLtd | 45 | |
| Masaaki Hasegawa | Sugi Holdings CoLtd | N/A | |
| Hsiao Wang | Walgreens Boots Alliance | 50 | |
| Fung Tsang | Beijing Tong Ren | 46 | |
| Li Feng | Beijing Tong Ren | 47 | |
| Holly May | Walgreens Boots Alliance | 41 | |
| Zheng Shen | Beijing Tong Ren | 49 | |
| Makoto Kasai | Sugi Holdings CoLtd | N/A | |
Management Performance
| Return On Equity | -26.29 | |||
| Return On Asset | 0.0038 |
Rite Aid Leadership Team
Elected by the shareholders, the Rite Aid's board of directors comprises two types of representatives: Rite Aid inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rite. The board's role is to monitor Rite Aid's management team and ensure that shareholders' interests are well served. Rite Aid's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rite Aid's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Heyward Donigan, President, Chief Executive Officer, Director | ||
| Elizabeth Burr, Independent Director | ||
| Frank Vitrano, Chief Officer | ||
| Angele RobinsonGaylord, Senior Vice President - Store Development | ||
| Bari Harlam, Independent Director | ||
| Christopher Hall, VP Services | ||
| Trent Kruse, Senior Vice President of Investor Relations, Treasury | ||
| Arun Nayar, Independent Director | ||
| Jessica Kazmaier, Ex Officer | ||
| Paul Gilbert, General Counsel, Company Secretary | ||
| Brian Hoover, Chief Accounting Officer | ||
| Katherine Quinn, Independent Director | ||
| Bruce Bodaken, Independent Chairman of the Board | ||
| Kevin Lofton, Independent Director | ||
| Marcy Syms, Independent Director | ||
| Byron Purcell, VP Treasurer | ||
| Chris Bohrer, Senior Vice President - Payor and Strategic Initiatives | ||
| Justin Mennen, Senior Vice President, Chief Information Officer | ||
| Erik Keptner, Senior Vice President Chief Marketing Officer | ||
| Roxanne Schwans, Senior Vice President - Market Access and Pharmacy Purchasing | ||
| Louis Miramontes, Independent Director | ||
| Jocelyn Konrad, Executive Vice President - Pharmacy and Retail Operations | ||
| Matthew Schroeder, Chief Financial Officer, Senior Vice President | ||
| Joy Seusing, VP Officer | ||
| Robert Knowling, Independent Director | ||
| Heyward BA, CEO Pres | ||
| Andre Persaud, Executive Vice President - Retail | ||
| James Peters, Chief Operating Officer |
Rite Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rite Aid a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -26.29 | |||
| Return On Asset | 0.0038 | |||
| Profit Margin | (0.04) % | |||
| Operating Margin | 0 % | |||
| Current Valuation | 6.53 B | |||
| Shares Outstanding | 56.52 M | |||
| Shares Owned By Insiders | 3.68 % | |||
| Shares Owned By Institutions | 47.29 % | |||
| Price To Book | 3.46 X | |||
| Price To Sales | 0.01 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Rite Stock
Rite Aid financial ratios help investors to determine whether Rite Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rite with respect to the benefits of owning Rite Aid security.